Astarita, A.; Mingrone, G.; Airale, L.; Cesareo, M.; Colomba, A.; Catarinella, C.; Leone, D.; Gay, F.; Bringhen, S.; Veglio, F.;
et al. Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study. Cancers 2023, 15, 955.
https://doi.org/10.3390/cancers15030955
AMA Style
Astarita A, Mingrone G, Airale L, Cesareo M, Colomba A, Catarinella C, Leone D, Gay F, Bringhen S, Veglio F,
et al. Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study. Cancers. 2023; 15(3):955.
https://doi.org/10.3390/cancers15030955
Chicago/Turabian Style
Astarita, Anna, Giulia Mingrone, Lorenzo Airale, Marco Cesareo, Anna Colomba, Cinzia Catarinella, Dario Leone, Francesca Gay, Sara Bringhen, Franco Veglio,
and et al. 2023. "Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study" Cancers 15, no. 3: 955.
https://doi.org/10.3390/cancers15030955
APA Style
Astarita, A., Mingrone, G., Airale, L., Cesareo, M., Colomba, A., Catarinella, C., Leone, D., Gay, F., Bringhen, S., Veglio, F., Milan, A., & Vallelonga, F.
(2023). Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study. Cancers, 15(3), 955.
https://doi.org/10.3390/cancers15030955
